Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy

Journal of Midwifery and Women's Health

Volumn 58, Issue 4, 2013, Pages 383-388

  O'Connor, Alane B ^a,b   Collett, Abigail ^c   Alto, William A ^d,e   O'Brien, Liam M ^f,g  

^a Faculty of Maine Dartmouth Family Medicine Residency in Fairfield   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF NURSING   (United States)

^c Colby in Waterville ^*  (United States)

^d Faculty of Swedish Family Medicine Residency Program   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Department of Mathematics and Statistics at Colby ^*  (United States)

^g UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Breastfeeding; Buprenorphine; Neonatal abstinence syndrome; Opioid dependence; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; BUPRENORPHINE; ILLICIT DRUG; OPIATE; PHENOBARBITAL;

ADULT; ARTICLE; BREAST FEEDING; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OPIATE ADDICTION; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SCORING SYSTEM; WITHDRAWAL SYNDROME;

BREASTFEEDING; BUPRENORPHINE; NEONATAL ABSTINENCE SYNDROME; OPIOID DEPENDENCE; PREGNANCY;

ADULT; ANALGESICS, OPIOID; BREAST FEEDING; BUPRENORPHINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84881519893     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/jmwh.12009     Document Type: Article

References (37)

1. Johnson R, Jones H, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2 Suppl):S87-S101.
2. Bolnick JM, Rayburn WF. Substance use disorders in women: special considerations during pregnancy. Obstet Gynecol Clin North Am. 2003;30(3):545-558.
3. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Obstet Gynecol Clin North Am. 1998;25(1):139-151.
4. Bell JR, Butler B, Lawrance A, et al. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug Alcohol Depend. 2009;104(1-2):73-77.
5. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-2331.
6. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79(1):1-10.
7. Czerkes M, Blackstone J, Pulvino J. Buprenorphine versus methadone treatment for opiate addiction in pregnancy, an evaluation of neonatal outcomes. Presentation at the American College of Obstetricians and Gynecologists' 58th Annual Clinical on May 18, 2010.
8. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008;96(1-2):69-78.
9. Lejeune C, Simmat-Durand L, Gourarier L, et al. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend. 2006;82(3):250-257.
10. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101(2):275-281.
11. Alto WA, O'Connor AB. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol. 2011;205(4):302-308.
12. Nocon JJ. Buprenorphine in pregnancy: the advantages (letter to the editor). Addiction. 2006;101(4):608-609.
13. Binder T, Vavrinková B. Prospective randomized comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birth weight of newborns, early postpartum adaption and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett. 2008;29(1):80-86.
14. American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776-789.
15. American College of Obstetricians and Gynecologists and the American Society of Addiction Medicine. Opioid abuse, dependency and addiction during pregnancy. Committee opinion No. 524. Obstet Gynecol. 2012;119(5):1070-1076.
16. Johnson RE, Jones HE, Jasinski DR, et al. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 2001;63(1):97-103.
17. Lindemalm S, Nydert P, Svensson J-O, et al. Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact. 2009;25(2):199-205.
18. Grimm D, Pauly E, Poschl J, et al. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit. 2005;27(4):526-530.
19. Marquet P, Chevrel J, Lavignasse P, et al. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62(5):569-571.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Publishing; 2000.
21. Hudak ML, Tan RC, and the committee on drugs and the committee on fetus and newborn. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540-e560.
22. US Census Bureau. Maine, state and county facts, 2011. Available at: http://quickfacts.census.gov/qfd/states/23000.html. Accessed October 28, 2012.
23. Wachman EM, Byun J, Philipp, BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med. 2010;5(4):159-164.
24. Jansson LM, Velez M, Harrow C. Methadone maintenance and lactation: a review of the literature and current management guidelines. J Hum Lact. 2004;20(1):62-71.
25. UNICEF. Implementing the UNICEF/WHO baby friendly hospital initiative in the US. Available at: http://www.babyfriendlyusa.org/eng/01.html. Accessed July 3, 2012.
26. US Centers for Disease Control and Prevention. Breastfeeding report card - United States, 2011. Available at: http://www.cdc.gov/breastfeeding/pdf/2011BreastfeedingReportCard.pdf. Accessed July 3, 2012.
27. Thulier D, Mercer J. Variables associated with breastfeeding duration. J Obstet Gynecol Neonatal Nurs. 2009;38(3):259-268.
28. Averbuch T, Spatz D. Breastfeeding mothers and violence: what nurses need to know. Am J Matern Child Nurs. 34(5):284-289.
29. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr. 1991;118(6):933-937.
30. Isemann B, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol. 2011;31(1):25-29.
31. Malpas TJ, Darlow BA. Neonatal abstinence syndrome following abrupt cessation of breastfeeding. N Z Med J. 1999;112(1080):12-13.
32. Liu AJW, Nanan R. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 2008;121(4):869.
33. Van Sleuwen BE, Engelberts AC, Boere-Boonekamp MM, et al. Swaddling: a systematic review. Pediatrics. 2007;120(4):e1097-e1106.
34. Abrahams RR, Kelly SA, Payne S, et al. Rooming-in compared with standard care for newborns of mothers using methadone and heroin. Can Fam Physician. 2007;53(10):1722-1730.
35. Dysart K, Hsieh HC, Kaltenbach K, Greenspan JS. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome. J Perinat Med. 2007;35(4):344-346.
36. Choo RE, Huestis MAS, Schroeder JR, et al. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004;75(3):253-260.
37. Levinson-Castiel R, Merlob, P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173-176.